Regenerative Breast Implants Will Soon Be a Reality

This next generation breast implant technology is designed to regenerate natural breast tissue without immune response, shaping the very future of reconstructive and aesthetic breast implant procedures.
This next generation breast implant technology is designed to regenerate natural breast tissue without immune response, shaping the very future of reconstructive and aesthetic breast implant procedures.
Image by alimyakubov at Adobe Stock

Currently the global breast implant market is estimated to be $3 billion, while breast reconstruction and augmentation procedures represent the second most common plastic surgery procedure performed worldwide. The most common procedures utilize synthetic breast implantations made of silicone, an artificial substitution for natural regenerated tissue with a risk of complications. However, this is all about to change, as CollPlant Biotechnologies and Stratasys Ltd. have commenced their pre-clinical study with 200cc commercial-sized regenerative implants printed on a Stratasys Origin 3D printer. This next generation breast implant technology is designed to regenerate natural breast tissue without immune response, shaping the very future of reconstructive and aesthetic breast implant procedures. 

Log in to view the full article
More in Research